Manufacturers Life Insurance Company, The Avrobio, Inc. Transaction History

Manufacturers Life Insurance Company, The

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 20, 2022	SELL	$1.29 - $4.04 $27,317 - $85,551	-21,176 Closed	0 $0
Q4 2021 Feb 16, 2022	SELL	$3.45 - $6.05 $18,033 - $31,623	-5,227 Reduced 19.8%	21,176 $82,000
Q3 2021 Nov 12, 2021	BUY	$5.53 - $9.28 $17,546 - $29,445	3,173 Added 13.66%	26,403 $147,000
Q2 2021 Aug 12, 2021	BUY	$7.84 - $12.6 $10,780 - $17,325	1,375 Added 6.29%	23,230 $207,000
Q1 2021 May 03, 2021	BUY	$10.54 - $19.3 $21,280 - $38,966	2,019 Added 10.18%	21,855 $277,000
Q4 2020 Feb 12, 2021	BUY	$12.79 - $17.1 $14,427 - $19,288	1,128 Added 6.03%	19,836 $277,000
Q2 2020 Aug 10, 2020	BUY	$12.19 - $22.96 $47,967 - $90,347	3,935 Added 26.64%	18,708 $329,000
Q1 2020 May 15, 2020	BUY	$10.08 - $27.21 $16,259 - $43,889	1,613 Added 12.26%	14,773 $230,000
Q4 2019 Feb 14, 2020	BUY	$13.05 - $21.88 $2,296 - $3,850	176 Added 1.36%	13,160 $265,000
Q3 2019 Nov 12, 2019	BUY	$14.12 - $23.44 $35,215 - $58,459	2,494 Added 23.78%	12,984 $197,000
Q2 2019 Aug 14, 2019	BUY	$13.21 - $27.29 $138,572 - $286,272	10,490 New	10,490 $171,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.